Track Jagsonpal Pharmaceuticals Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Jagsonpal Pharmaceuticals Limited JAGSNPHARM.NS · Stock Open Jagsonpal Pharmaceuticals Limited in new tab

231.73 INR
P/E
36.11
EPS
6.71
Yield
1.71%
Safety Score
60
P/B
6.15
ROE
16.70
Beta
-0.28
Loading chart...
Key Metrics
P/E36.11
EPS6.71
Book Value39.40
Price to Book6.15
Debt/Equity2.96
% Insiders76.057%
Growth
Revenue Growth0.09%
Earnings Growth0.25%
Dividend
Dividend Yield1.71%
Annual dividends4.00 INR
Ex-Div. DateSept. 4, 2026
Payout36.63%
5y avg Yield0.87%

DCF Valuation

Tweak assumptions to recompute fair value for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Jagsonpal Pharmaceuticals Limited Logo Jagsonpal Pharmaceuticals Limited Analysis (JAGSNPHARM.NS)

India Health Care Official Website Stock

Is Jagsonpal Pharmaceuticals Limited a good investment? Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) is currently trading at 231.73 INR.

In terms of valuation, the stock trades at a P/E ratio of 36.11. This high multiple suggests investors have priced in significant future growth expectations.

For income investors, Jagsonpal Pharmaceuticals Limited pays a dividend yield of 1.71%. With a payout ratio of 37%, the dividend appears sustainable.

Investor FAQ

Does Jagsonpal Pharmaceuticals Limited pay a dividend?

Yes, it pays an annual dividend of 4.00 INR (1.71% yield).

What asset class is Jagsonpal Pharmaceuticals Limited?

Jagsonpal Pharmaceuticals Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.

Exchange Ticker
NSI (India) JAGSNPHARM.NS
Trades
Dividend Yield
1.71%
5y avg 0.87%
Annual Dividends
4.00INR
Next Ex. Div Date
Sept. 4, 2026
Payout Ratio
36.63%
Dividend History paid per year (INR)
Historical Dividends
Year Total Dividends
▸2026
4.00 INR
Oct. 18, 2026 4.0000
▸2025
2.50 INR
Oct. 24, 2025 2.5000
▸2024
5.00 INR
Oct. 18, 2024 5.0000
▸2023
5.00 INR
Sept. 30, 2023 5.0000
▸2021
5.00 INR
Nov. 18, 2021 4.0000
Oct. 30, 2021 1.0000
▸2020
1.25 INR
Oct. 30, 2020 1.2500
▸2019
0.63 INR
Oct. 30, 2019 0.6250
▸2018
0.10 INR
Oct. 28, 2018 0.1000
▸2017
0.10 INR
Oct. 29, 2017 0.1000
▸2016
0.25 INR
Sept. 21, 2016 0.2500
▸2015
0.10 INR
Oct. 30, 2015 0.1000
▸2014
0.50 INR
Oct. 30, 2014 0.5000
▸2013
1.25 INR
Oct. 30, 2013 1.2500
▸2012
1.25 INR
Oct. 28, 2012 1.2500
▸2011
0.50 INR
Oct. 30, 2011 0.5000
▸2010
1.25 INR
Oct. 25, 2010 1.2500
▸2009
0.25 INR
Oct. 30, 2009 0.2500
▸2008
0.10 INR
Nov. 1, 2008 0.1000
▸2007
0.25 INR
Nov. 1, 2007 0.2500
▸2006
0.25 INR
Oct. 13, 2006 0.2500
▸2005
1.00 INR
Oct. 13, 2005 1.0000
▸2004
1.00 INR
Sept. 15, 2004 1.0000
▸2003
30.00 INR
June 18, 2003 30.0000
Upcoming Dividends
Name Payment Date Status Amount
Jagsonpal Pharmaceuticals Limited Oct 18, 2026 Upcoming 4.0 INR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion